Dr Lal Pathlabs Ltd Board of Directors
Board of Directors at Dr Lal Pathlabs Ltd
Non Executive Director
Independent Director
Executive Chairman
Independent Director
Managing Director
Key Highlights
- Arvind Lal joins the board as Chairman/ED & CEO, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vandana Lal joins the board as WTD & Executive Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Arun Duggal joins the board as Lead Independent Non Executive Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Rohit Bhasin joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Somya Satsangi joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Dr Lal Pathlabs Ltd
NSE: LALPATHLAB
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 24 Jul 2026 | 1756.7 |
| 23 Jul 2026 | 1686.7 |
| 22 Jul 2026 | 1699.65 |
| 21 Jul 2026 | 1700.75 |
| 20 Jul 2026 | 1694.6 |
| 17 Jul 2026 | 1686.25 |
| 16 Jul 2026 | 1734.15 |
| 15 Jul 2026 | 1723 |
| 14 Jul 2026 | 1743.4 |
| 13 Jul 2026 | 1726.45 |
Company Fundamentals for Dr Lal Pathlabs Ltd
Market Cap
29,448 Cr
EPS
31.1
P/E Ratio (TTM)
54.2
P/B Ratio (TTM)
11.3
Day’s High
1776.5
Day’s Low
1650.45
DTE
0.1
ROE
20.1
52 Week High
1803.6
52 Week Low
1272.0
ROCE
25.6
Market Price of Dr Lal Pathlabs Ltd
1M
1Y
3Y
5Y
Dr Lal Pathlabs Ltd News Hub
Dr Lal Pathlabs allots 93,900 equity shares under ESOP
Dr Lal Pathlabs has allotted 93,900 equity shares under Dr. Lal PathLabs Employee Stock Option Plan,
Read more
13 Aug 24
Board of Dr. Lal PathLabs recommends interim dividend
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 7 Augus
Read more
07 Aug 24
Dr Lal Pathlabs consolidated net profit rises 28.81% in the June 2024 quarter
Net profit of Dr Lal Pathlabs rose 28.81% to Rs 106.40 crore in the quarter ended June 2024 as again
Read more
07 Aug 24
Dr Lal PathLabs gains after Q1 PAT rises 29% YoY to Rs 108 cr
Revenue from operations increased 11.26% YoY to Rs 601.9 crore during the quarter. Profit before tax
Read more
07 Aug 24
